TOMI Environmental Solutions reports improved margins and expands into new sectors, despite a net loss, while focusing on global registrations and SteraMist adoption.
Apellis Pharmaceuticals reported strong revenues for SYFOVRE and EMPAVELI, but the article suggests AI stocks might offer greater investment potential.